US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Potassium Phosphate

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. NDC 15082-926-25 D-0954-2017
Class II · Moderate risk Terminated

Quelicin

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. NDC 15082-814-67 D-0953-2017
Class II · Moderate risk Terminated

Cyclobenzaprine HCl Tablets

Reason Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

Apace KY LLC D-1036-2017
Class II · Moderate risk Terminated

Amantadine HCl Capsules

Reason Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

Apace KY LLC D-1035-2017
Class II · Moderate risk Terminated

Succinylcholine Chloride

Reason Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier

Fagron Compounding Services LLC dba Fagron Sterile Services D-0946-2017
Class II · Moderate risk Terminated

Ibuprofen Tablets

Reason Presence of foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg.

Time-Cap Laboratories, Inc. NDC 49483-603-50 D-1055-2017
Class II · Moderate risk Terminated

Clindamycin Injection USP

Reason Lack of Assurance of Sterility

Alvogen, Inc NDC 47781-464-69 D-0941-2017
Class II · Moderate risk Terminated

Clindamycin Injection USP

Reason Lack of Assurance of Sterility

Alvogen, Inc NDC 47781-463-69 D-0940-2017
Class II · Moderate risk Terminated

Clindamycin Injection USP

Reason Lack of Assurance of Sterility

Alvogen, Inc NDC 47781-462-69 D-0939-2017
Class II · Moderate risk Terminated

Morphine Sulfate Oral Solution

Reason Defective container: Oral solution leaking from container.

Tris Pharma Inc. NDC 27808-082-01 D-1126-2017
Class II · Moderate risk Terminated

Neut Sodium Bicarbonate 4%

Reason Lack of Sterility Assurance

Hospira a Pfizer Company NDC 0409-6609-02 D-1049-2017
Class II · Moderate risk Terminated

8.4% Sodium Bicarbonate Inj.

Reason Lack of Sterility Assurance

Hospira a Pfizer Company D-1047-2017
Class II · Moderate risk Terminated

Potassium Phosphates Inj.

Reason Lack of Sterility Assurance

Hospira a Pfizer Company D-1046-2017
Class II · Moderate risk Terminated

CVS Health Baby Eczema Moisturizing Cream

Reason Microbial Contamination of Non Sterile Products; out of specification Total Plate Count

Sigan Industries Inc. D-0975-2017
Class II · Moderate risk Terminated

NitroGlycerin

Reason Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Advanced Pharma Inc. NDC 15082-863-61 D-0119-2018
Class II · Moderate risk Terminated

NitroGlycerin

Reason Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Advanced Pharma Inc. NDC 15082-863-67 D-0118-2018
Class II · Moderate risk Terminated

NitroGlycerin 100 mcg/mL QS 5% Dextrose Inj

Reason Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Advanced Pharma Inc. NDC 15082-818-62 D-0117-2018
Class II · Moderate risk Terminated

NitroGlycerin 1 mg/10 mL in 5% Dextrose Inj

Reason Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Advanced Pharma Inc. NDC 15082-818-61 D-0116-2018
Class II · Moderate risk Terminated

VenomX

Reason GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Phillips Co. NDC 43074-207-01 D-0952-2017